TY - JOUR
T1 - Incorporating system latency associated with real-time target tracking radiotherapy in the dose prediction step
AU - Roland, Teboh
AU - Mavroidis, Panayiotis
AU - Shi, Chengyu
AU - Papanikolaou, Nikos
PY - 2010
Y1 - 2010
N2 - System latency introduces geometric errors in the course of real-time target tracking radiotherapy. This effect can be minimized, for example by the use of predictive filters, but cannot be completely avoided. In this work, we present a convolution technique that can incorporate the effect as part of the treatment planning process. The method can be applied independently or in conjunction with the predictive filters to compensate for residual latency effects. The implementation was performed on TrackBeam (Initia Ltd, Israel), a prototype real-time target tracking system assembled and evaluated at our Cancer Institute. For the experimental system settings examined, a Gaussian distribution attributable to the TrackBeam latency was derived with σ = 3.7 mm. The TrackBeam latency, expressed as an average response time, was deduced to be 172 ms. Phantom investigations were further performed to verify the convolution technique. In addition, patient studies involving 4DCT volumes of previously treated lung cancer patients were performed to incorporate the latency effect in the dose prediction step. This also enabled us to effectively quantify the dosimetric and radiobiological impact of the TrackBeam and other higher latency effects on the clinical outcome of a real-time target tracking delivery.
AB - System latency introduces geometric errors in the course of real-time target tracking radiotherapy. This effect can be minimized, for example by the use of predictive filters, but cannot be completely avoided. In this work, we present a convolution technique that can incorporate the effect as part of the treatment planning process. The method can be applied independently or in conjunction with the predictive filters to compensate for residual latency effects. The implementation was performed on TrackBeam (Initia Ltd, Israel), a prototype real-time target tracking system assembled and evaluated at our Cancer Institute. For the experimental system settings examined, a Gaussian distribution attributable to the TrackBeam latency was derived with σ = 3.7 mm. The TrackBeam latency, expressed as an average response time, was deduced to be 172 ms. Phantom investigations were further performed to verify the convolution technique. In addition, patient studies involving 4DCT volumes of previously treated lung cancer patients were performed to incorporate the latency effect in the dose prediction step. This also enabled us to effectively quantify the dosimetric and radiobiological impact of the TrackBeam and other higher latency effects on the clinical outcome of a real-time target tracking delivery.
UR - http://www.scopus.com/inward/record.url?scp=77951184224&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951184224&partnerID=8YFLogxK
U2 - 10.1088/0031-9155/55/9/015
DO - 10.1088/0031-9155/55/9/015
M3 - Article
C2 - 20400813
AN - SCOPUS:77951184224
SN - 0031-9155
VL - 55
SP - 2651
EP - 2668
JO - Physics in Medicine and Biology
JF - Physics in Medicine and Biology
IS - 9
ER -